May 31, 2019
Unexpected Prevalence of Rare High-Risk HPV Types Demonstrates Utility of Zeesan Biotech Assay in Low-Resource Setting May 29, 2019 | Madeleine Johnson NEW YORK (GenomeWeb) – […]
May 28, 2019
San Jose, CA, USA. May 21, 2019 – QuanDx is the designated U.S. distributor of a PCR-based assay from Zeesan Biotech designed to detect and identify […]
March 10, 2015
Menlo Park, CA, USA. Mar. 10th, 2015 QuanDx Inc, a Biotechnology Company developing and commercializing innovative molecular diagnostic tests, announced that Resnova S.r.l. a Rome based […]
January 11, 2016
San Jose, CA, USA. Jan. 11, 2016 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that […]
September 24, 2015
San Francisco, CA, USA. Sept. 24th, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, welcome you to […]
November 24, 2015
San Francisco, CA, USA. Nov. 24, 2015 QuanDx Inc., a biotechnology company developing and commercializing innovative molecular diagnostic tests for personalized cancer treatment, today announced that […]